TORONTO, March 25, 2025 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the " Company " or " Blueberries "), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce a non-brokered private placement consisting of the sale of 96,064,935 common shares (" Common Shares ") at a price of C$0.011 per Common Share for aggregate gross proceeds of... Read More

TORONTO, March 07, 2025 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries "), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce a non-brokered private placement consisting of the sale of 96,064,935 common shares (“ Common Shares ”) at a price of C$0.011 per Common Share for aggregate gross proceeds of... Read More

TORONTO, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries "), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, announces a non-brokered private placement consisting of the sale of 180,716,00 common shares (“ Common Shares ”) at a price of C$0.011 per Common Share for aggregate gross proceeds of approximately... Read More

TORONTO, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries "), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, announces a non-brokered private placement consisting of the sale of 180,716,000 common shares (“ Common Shares ”) at a price of C$0.011 per Common Share for aggregate gross proceeds of... Read More

TORONTO, May 30, 2023 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S. (“ BBSAS ”), a leading player in the cannabis industry (together the “ Company ” or " Blueberries ") is thrilled to announce its exceptional financial and business performance for the first quarter ended March 31, 2023. The company has demonstrated remarkable growth, doubling its... Read More

KELOWNA, British Columbia, April 26, 2023 (GLOBE NEWSWIRE) -- Allied Corp . ("Allied" or the “Company”) ( OTCQB: ALID ), a leading cannabis cultivator based in Colombia and one of the few to have executed on international exports, is pleased to announce that it has signed a joint venture agreement with Blueberries Medical Corp. (“Blueberries") (OTC:BBRRF), one of the largest extraction companies in Colombia, to produce... Read More

TORONTO, April 24, 2023 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S. (“ BBSAS ”), the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the “ Company ” or " Blueberries "), is pleased to report its financial results for the year ended December 31, 2022. Blueberries has... Read More

TORONTO, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “ Company ” or “ Blueberries ”), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, announces the completion of a non-brokered private placement consisting of the sale of 54,498,889 common shares (“ Common Shares ”) at a price of CAD$0.027 per Common Share for aggregate gross... Read More

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of Blueberries S.A.S. (“ BBSAS ”), the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the “ Company ” or " Blueberries "), is pleased to report its financial results for the quarter ended on June 30, 2022. Today, Blueberries has filed its unaudited condensed interim... Read More

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries "), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, announces that has achieved several CBD and non-psychoactive derivatives shipments to customers in Argentina, and up to date has exported a total of more than 60 kg to 6 different buyers. Quality validation processes with larger... Read More

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of Blueberries S.A.S. (“ BBSAS ”), the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the “ Company ” or " Blueberries "), is pleased to report its financial results for the quarter ended on March 31, 2022. Today, Blueberries has filed its unaudited condensed... Read More

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S. (“ BBSAS ”), the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the “ Company ” or " Blueberries "), is pleased to report its financial results for the year ended December 31, 2021. Blueberries has filed today its audited consolidated financial... Read More

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA), the Canadian parent of Blueberries S.A.S. (“ BBSAS ”), the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the “ Company ” or " Blueberries "), is pleased to report its financial results for the quarter ended September 30, 2021. Today, Blueberries has filed its unaudited condensed... Read More

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the "Company" or "Blueberries"), a licensed Latin American producer of medical Cannabis and Cannabis-derived products, today announces that its wholly owned subsidiary Blueberries S.A.S. in Bogota, Colombia, obtained the registration of its agronomic operation area as a plant breeding unit and exporter of selected seeds. This authorization by the Colombian... Read More

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries "), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, today announced its wholly owned subsidiary Blueberries SAS has exported a total of 150 kg of premium CBD 5% Full Spectrum Oil to Futura Farms Peru, a leading licensed distributor serving the Peruvian market. This is the Company´s largest... Read More

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries "), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce webcast link for the Annual General Meeting of the shareholders of Blueberries Medical Corp. (the “AGM” or “Meeting”). The AGM will be held on Wednesday, September 29 th , 2021 at 1:00 pm Eastern Time. Due to the fact... Read More

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries "), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, announces the completion of a non-brokered private placement consisting of the sale of 20,813,817 common shares (“ Common Shares ”) at a price of C$0.10 per Common Share for aggregate gross proceeds of C$1,901,382 (or approximately... Read More

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S. (“ BBSAS ”), the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the “ Company ” or " Blueberries "), is pleased to report its financial results for the quarter ended June 30, 2021. Today, Blueberries has filed its unaudited condensed interim... Read More

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S. (“ BBSAS ”), the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the “ Company ” or " Blueberries "), is pleased to report its financial results for the quarter ended March 31, 2021. Today, Blueberries has filed its unaudited condensed interim... Read More

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S. (“ BBSAS ”), the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the “ Company ” or “ Blueberries ”), is pleased to report its financial results for the year ended December 31, 2020. Blueberries has filed today its audited consolidated financial... Read More

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) the Canadian parent of Blueberries S.A.S., the premier Latin American licensed cultivator and producer of medicinal cannabis and medicinal-grade cannabis extracts, (together the “ Company ” or “ Blueberries ”), today announced that it has signed a Framework Agreement with Mechelen S.A., a subsidiary of YVY Life Sciences (“ YVY ”) for mutual development of strains... Read More

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries "), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, today announced its wholly owned subsidiary Blueberries SAS will supply premium, formulated cannabis oil to Futura Farms, a licensed distributor serving the Peruvian market. This is the Company's first agreement in Peru and the next step in... Read More

Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “ Company ” or " Blueberries "), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce the appointment of José María Forero, the former Global Head of B2B of Clever Leaves Holdings Inc. (NASDAQ: CLVR) (“ Clever Leaves ”) as President of Latin American Operations, effective February 16, 2021. Mr. Forero... Read More